Skip to main content

Advertisement

Log in

Clinical and laboratory features of patients with osteomalacia initially presenting with neurological manifestations

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

Patients with osteomalacia often visit the neurology department with conditions mimicking other myopathies. We analyzed clinical features of osteomalacia patients who visited the neurology department. These patients frequently presented with hypocalcemia, hypovitaminosis D, and pain with less severe weakness. Osteomalacia should be considered when patients present with pain and weakness.

Introduction

Osteomalacia is a disease of bone metabolism; however, some patients with osteomalacia initially visit the neurology department. As these patients often complain of weakness and gait disturbance, osteomalacia can be confused with other myopathies. We analyzed the clinical features of patients with osteomalacia who visited the neurology department.

Methods

We retrospectively reviewed the medical records. Osteomalacia was diagnosed based on symptoms, laboratory features, and imaging results. We compared the characteristics of patients with osteomalacia who visited the neurology department with (1) those who did not visit the neurology department and (2) patients with idiopathic inflammatory myopathy.

Results

Eighteen patients with osteomalacia visited the neurology department (NR group). The common etiologies in the NR group included tumors or antiepileptic medication, whereas antiviral medication was the most common in patients who did not visit the neurology department (non-NR group). The NR group showed lower serum calcium (p = 0.004) and 25-hydroxyvitamin D (p = 0.006) levels than the non-NR group. When compared with patients with inflammatory myopathy, both groups showed proximal dominant weakness. However, pain was more common in osteomalacia than in myopathy (p = 0.008), and patients with osteomalacia showed brisk deep tendon reflex more often (p = 0.017). Serum calcium (p = 0.003) and phosphate (p < 0.001) levels were lower in osteomalacia than in myopathy.

Conclusions

It was not uncommon for patients with osteomalacia to visit the neurology department. The clinical presentation of these patients can be more complex owing the superimposed neurological disease and accompanying hypocalcemia. Osteomalacia should be considered when patients present with pain and weakness.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
€32.70 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Finland)

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bhan A, Rao AD, Rao DS (2010) Osteomalacia as a result of vitamin D deficiency. Endocrinol Metab Clin N Am 39:321–331

    Article  CAS  Google Scholar 

  2. Girgis CM, Wong T, Ngu MC, Emmett L, Archer KA, Chen RC et al (2011) Hypophosphataemic osteomalacia in patients on adefovir dipivoxil. J Clin Gastroenterol 45:468–473

    Article  PubMed  CAS  Google Scholar 

  3. Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT (2017) Tumour-induced osteomalacia. Nat Rev Dis Primers 3:17044

    Article  PubMed  Google Scholar 

  4. Pfeifer M, Begerow B, Minne HW (2002) Vitamin D and muscle function. Osteoporos Int 13:187–194

    Article  PubMed  CAS  Google Scholar 

  5. Irani PF (1976) Electromyography in nutritional osteomalacic myopathy. J Neurol Neurosurg Psychiatry 39:686–693

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Smith R, Stern G (1969) Muscular weakness in osteomalacia and hyperparathyroidism. J Neurol Sci 8:511–520

    Article  PubMed  CAS  Google Scholar 

  7. Schott GD, Wills MR (1976) Muscle weakness in osteomalacia. Lancet 1:626–629

    Article  PubMed  CAS  Google Scholar 

  8. Benhamou J, Fontanges E, Streichenberger N, Petiot P (2015) Severe osteomalacia mimicking progressive myopathy. Int J Rheum Dis 20:1803–1804. https://doi.org/10.1111/1756-185x.12641

    Article  PubMed  Google Scholar 

  9. Fukumoto S, Ozono K, Michigami T, Minagawa M, Okazaki R, Sugimoto T, Takeuchi Y, Matsumoto T (2015) Pathogenesis and diagnostic criteria for rickets and osteomalacia—proposal by an expert panel supported by Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research and the Japan Endocrine Society. Endocr J 62:665–671

    Article  PubMed  CAS  Google Scholar 

  10. RMC Trial Group (2009) Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study. Lancet Neurol 8:158–164

    Article  CAS  Google Scholar 

  11. Chong WH, Molinolo AA, Chen CC, Collins MT (2011) Tumor-induced osteomalacia. Endocr Relat Cancer 18:R53–R77

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Kurella Tamura M, Feldman HI (2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63:713–735

    Article  PubMed  Google Scholar 

  13. Al-Said YA, Al-Rached HS, Al-Qahtani HA, Jan MM (2009) Severe proximal myopathy with remarkable recovery after vitamin D treatment. Can J Neurol Sci 36:336–339

    Article  PubMed  Google Scholar 

  14. Ripellino P, Terazzi E, Bersano E, Cantello R (2013) Adult osteomalacia: a treatable cause of “fear of falling” gait. Neurology 80:2079

    Article  PubMed  Google Scholar 

  15. Ladha SS, Whitaker MD, Bosch EP (2006) Oncogenic osteomalacia: muscular weakness and multiple fractures. Neurology 67:364–365

    Article  PubMed  Google Scholar 

  16. Panda S, Sharma K (2013) Osteomalacia induced peripheral neuropathy after obesity reduction surgery. Ann Indian Acad Neurol 16:690–692

    Article  PubMed  PubMed Central  Google Scholar 

  17. Noh CK, Lee MJ, Kim BK, Chung YS (2013) A case of nutritional osteomalacia in young adult male. J Bone Metab 20:51–55

    Article  PubMed  PubMed Central  Google Scholar 

  18. Assenza G, Campana C, Tombini M, Cosimo Quattrocchi C, Giambattistelli F, Benvenga A, Pellegrino G, Assenza F, Vernieri F, di Lazzaro V (2013) Osteomalacic myopathy: an uncommon side effect of antiepileptic drugs. Muscle Nerve 48:837–838

    Article  PubMed  Google Scholar 

  19. Valmadrid C, Voorhees C, Litt B, Schneyer CR (2001) Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy. Arch Neurol 58:1369–1374

    Article  PubMed  CAS  Google Scholar 

  20. Pack AM (2003) The association between antiepileptic drugs and bone disease. Epilepsy Curr 3:91–95

    Article  PubMed  PubMed Central  Google Scholar 

  21. Teagarden DL, Meador KJ, Loring DW (2014) Low vitamin D levels are common in patients with epilepsy. Epilepsy Res 108:1352–1356

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Qari FA, Nasser TA (2013) Association between neurological and rheumatological manifestations in vitamin D deficiency and vitamin D levels. Pak J Med Sci 29:735–739

    Article  Google Scholar 

  23. Ishikawa T, Saito M, Morishita H, Watanabe I (1995) Effect of hypocalcemia on muscle in disorders of calcium metabolism. Acta Paediatr Jpn 37:367–369

    Article  PubMed  CAS  Google Scholar 

  24. Hirata D, Nagashima T, Saito S, Okazaki H, Kano S, Minota S (2002) Elevated muscle enzymes in a patient with severe hypocalcemia mimicking polymyositis. Mod Rheumatol 12:186–189

    Article  PubMed  CAS  Google Scholar 

  25. Murphy E, Williams GR (2009) Hypocalcaemia. Medicine 37:465–468

    Article  Google Scholar 

  26. Ali FE, Al-Bustan MA, Al-Busairi WA, Al-Mulla FA (2004) Loss of seizure control due to anticonvulsant-induced hypocalcemia. Ann Pharmacother 38:1002–1005

    Article  PubMed  Google Scholar 

  27. Gilchrist JM (1995) Osteomalacic myopathy. Muscle Nerve 18:360–361

    Article  PubMed  CAS  Google Scholar 

  28. Smith R, Stern G (1967) Myopathy, osteomalacia and hyperparathyroidism. Brain 90:593–602

    Article  PubMed  CAS  Google Scholar 

  29. Schubert L, DeLuca HF (2010) Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency. Arch Biochem Biophys 500:157–161

    Article  PubMed  CAS  Google Scholar 

  30. Policepatil SM, Caplan RH, Dolan M (2012) Hypocalcemic myopathy secondary to hypoparathyroidism. WMJ 111:173–175

    PubMed  Google Scholar 

  31. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Andersen H, Charles P, Eriksen EF (2000) Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int 66:419–424

    Article  PubMed  CAS  Google Scholar 

  32. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB (2004) Effect of vitamin D on falls: a meta-analysis. JAMA 291:1999–2006

    Article  PubMed  CAS  Google Scholar 

  33. Skaria J, Katiyar B, Srivastava T, Dube B (1975) Myopathy and neuropathy associated with osteomalacia. Acta Neurol Scand 51:37–58

    Article  PubMed  CAS  Google Scholar 

  34. Skaria J, Katiyar BC, Srivastava TP, Dube B (1975) Myopathy and neuropathy associated with osteomalacia. Acta Neurol Scand 51:37–58

    Article  PubMed  CAS  Google Scholar 

  35. Parsonage MJ, Wilkins EG, Snowden N, Issa BG, Savage MW (2005) The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy. HIV Med 6:341–346

    Article  PubMed  CAS  Google Scholar 

  36. Mateo L, Holgado S, Marinoso ML, Perez-Andres R, Bonjoch A, Romeu J et al (2016) Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients. Clin Rheumatol 35:1271–1279

    Article  PubMed  Google Scholar 

  37. Jeong HJ, Lee JM, Lee TH, Lee JY, Kim HB, Heo MH, Choi G, Chae JN, Kim JM, Kim SH, Kwon KY (2014) Two cases of hypophosphatemic osteomalacia after long-term low dose adefovir therapy in chronic hepatitis B and literature review. J Bone Metab 21:76–83

    Article  PubMed  PubMed Central  Google Scholar 

  38. Bingham CT, Fitzpatrick LA (1993) Noninvasive testing in the diagnosis of osteomalacia. Am J Med 95:519–523

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. M. Kim.

Ethics declarations

Conflicts of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, S.W., Hong, N., Rhee, Y. et al. Clinical and laboratory features of patients with osteomalacia initially presenting with neurological manifestations. Osteoporos Int 29, 1617–1626 (2018). https://doi.org/10.1007/s00198-018-4501-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-018-4501-1

Keywords

Navigation